SCHEMBL23958349

SCHEMBL23958349

O=c1c2cccc(Cl)c2nc(Nc2cccnc2)n1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 2/20 0.47
PIK3CD O00329 2/20 0.45
PIK3CG P48736 2/20 0.45
PIK3R1 P27986 1/20 0.45
PIK3CA P42336 1/20 0.45
PIK3CB P42338 1/20 0.45
ALOX12 P18054 1/20 0.43
RAD52 P43351 1/20 0.42
KMT2A Q03164 1/20 0.42
EGFR P00533 1/20 0.41
FGFR1 P11362 1/20 0.41
WEE1 P30291 1/20 0.41
PDE5A O76074 2/20 0.40
MAPT P10636 3/20 0.40
MDM2 Q00987 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
PSD A5PKW4 1/20 0.39
LOXL3 P58215 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23065084 0.93 PIK3CD (0.49) PDE7APIK3CDPIK3CGPIK3R1PIK3CA
SCHEMBL23065107 0.90 PDE7A (0.56) PDE7APIK3CDPIK3CGWEE1MAPT
SCHEMBL23958201 0.87 ALOX12 (0.43) PDE7AALOX12RAD52KMT2APDE5A
SCHEMBL23958356 0.87 ALOX12 (0.48) PDE7AALOX12RAD52KMT2APDE5A
SCHEMBL23958352 0.84 G6PD (0.44) ALOX12RAD52KMT2AMAPTMDM2
SCHEMBL24110995 0.83 ALOX12 (0.57) PDE7AALOX12RAD52KMT2APDE5A
SCHEMBL23958331 0.81 LOXL3 (0.47) PDE7AALOX12RAD52KMT2APDE5A
SCHEMBL23065144 0.81 PDE7A (0.52) PDE7APIK3CDPIK3CGPDE5AMAPT
SCHEMBL24110973 0.80 ALOX12 (0.47) PDE7AALOX12RAD52KMT2APDE5A
SCHEMBL30025728 0.80 TUBB4A (0.45) ALOX12RAD52KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed
WO-2021215537-A1 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 (JP) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 PDE7A 3371/4885PIK3CD 3088/4885PIK3CG 3250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.